Axonia Medical

Axonia Medical develops technology to rebuild and restore damaged peripheral or central nervous systems from tissue-engineered nerve grafts.

Axonia Medical is a privately owned-company located in Kalamazoo MI, founded by the University of Pennsylvania, Dr. Douglas H. Smith, The Robert A. Groff Endowed Professor and Vice Chairman for Research, Department of Neurosurgery, University of Pennsylvania, and Dr. Harry C. Ledebur, Fmr. Executive in Residence at Southwest Michigan Life Science Venture Fund. Axonia Medical is pioneering a revolutionary and proprietary approach to repair and restore damaged peripheral or central nervous systems using tissue-engineered nerve grafts (TENGs). By recapitulating the anatomy of the nervous system, TENGs are expected to bridge lost nervous tissue and jump-start regenerative mechanisms to achieve levels of functional recovery not possible with current technologies. As a result, TENGs may not only change the way nervous system injuries are treated, but also clinical expectations for restoration or recovery of sensory, motor and/or cognitive deficits